Article
Removal of Mannose-Ending Glycan at Asn2118 Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic Cells.
Frontiers in immunology - 1 Jan 2020
Delignat Sandrine, Rayes Julie, Dasgupta Suryasarathi, Gangadharan Bagirath, Denis Cécile V, Christophe Olivier D, Bayry Jagadeesh, Kaveri Srinivas V, Lacroix-Desmazes Sébastien
Abstract excerpt
The development of an immune response against therapeutic factor VIII is the major complication in hemophilia A patients. Oligomannose carbohydrates at N239 and/or N2118 on factor VIII allow its binding to the macrophage mannose receptor expressed on human dendritic cells, thereby leading to factor VIII endocytosis and presentation to CD4+ T lymphocytes. Here, we investigated whether altering the interaction of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
